Both baseline and most recent lipoproteinassociated. Both baseline and most recent lipoprotein associated phospholipase a2 activity levels are associated with coronary artery calcification in type 1 diabetes lipoprotein associated phospho lipoprotein associated phospholipase a2 lppla2 activity has previously been associated with coronary artery calcification cac, however this relationship has not been well studied in type 1 diabetes t1d. Lipoproteinassociated phospholipase a 2 mass was measured with an enzymelinked immunoassay according to previously described methods. Objectives the aim of this study was to examine the prognostic value of lipoprotein associated phospholipase a 2 lppla 2 associated with highdensity lipoprotein hdl hdllppla 2 in patients with stable coronary artery disease cad. The test is used to help predict your risk for cardiovascular disease and stroke. Lipoproteinassociated phospholipase a2 lppla 2 is a novel biomarker of vascularspecific inflammation that provides information about atherosclerotic plaque inflammation and stability. Patients with high lipoproteinassociated phospholipase a2 concentrations greater than or equal to 235 ngml are at increased risk for cardiovascular events including myocardial infarction and ischemic. Lppla2 is an enzyme which is usually bound to ldl, often called the bad cholesterol, in the blood and plays a role in the inflammation of blood vessels. Lipoproteinassociated phospholipase a2 is associated with.
This chapter is focused on the plasma form of pafacetylhydrolase pafah, a lipoproteinbound, calciumindependent phospholipase a 2 activity also referred to as lipoproteinassociated phospholipase a2 and pla2g7. Clinical chemistry, immunology and laboratory quality control, 2014. Lipoproteinassociated phospholipase a2 in coronary heart. Lipoproteinassociated phospholipase a2 activity and mass as. Lipoproteinassociated phospholipase a2 lppla2 appears to be relatively unique in its high specificity for and the causal pathway of plaque inflammation. The aim of the present study was to observe the role of lipoproteinassociated phospholipase a2 lppla2 and antithrombin iii atiii in. Product classification food and drug administration. Lipoproteinassociated phospholipase a2 is associated with angiographic. Lipoproteinassociated phospholipase a 2 lppla 2 has been implicated in development of atherosclerosis. Predictive value of combining the level of lipoproteinassociated. Measure lipoproteinassociated phospholipase a2 lppla 2, which in some studies has demonstrated more specificity than hscrp, when it is necessary to further stratify an individuals ascvd risk, especially in the presence of hscrp elevations grade a. Lipoproteinassociated phospholipase a 2 lppla 2 is an enzyme that appears to play a role in the inflammation of blood vessels and is thought to help promote atherosclerosis. We initially screened 620 patients, of whom 524 satis. This test measures the amount or activity of lppla 2 in the blood some recent studies have shown that lppla 2 is an independent risk marker for cardiovascular disease cvd, including coronary heart disease chd.
Lipoproteinassociated phospholipase a2 lppla2 appears to. The lipoproteinassociated phospholipase a2, immunoassay, system, test, is intended to measure lipoproteinassociated phospholipase a2 in human plasma in conjunction with clinical evaluation and other patient risk factors including biochemical analyses as an aid in. Lipoprotein associated phospholipase a2 lppla2 is an emerging inflammatory marker that is used to assess the risk for cardiovascular disease cvd and associated events. Lipoproteinassociated phospholipase a2 lppla2 elisa kits. Previously, studies have confirmed lipoproteinassociated phospholipase a2 lp pla2 as a novel type of inflammatory marker in coronary heart. It is believed to contribute to hardening of the arteries atherosclerosis lipoproteins carry cholesterol and fats through blood. Lipoproteinassociated phospholipase a2 lppla2, also known as platelet activating factor. After adding the product to the cart by clicking the button below you will see if there is a volume discount available. Recombinant human lipoproteinassociated phospholipase a2. Background lppla 2 is a novel risk factor for cardiovascular disease. The role of inflammation in atherosclerosis continues to emerge. High sensitivity creactive protein hscrp is a marker of metabolic syndrome ms and cardiovascular cv disease. The new lipoproteinassociated phospholipase a2 activity, serum, test is now available to the mayo clinic practice and mayo medical laboratories clients. The role of lppla2 in diabetes mellitus is controversial and analyses, especially in adolescents with type 2 diabetes t2d, are missing.
Lipoproteinassociated phospholipase a2 lppla2 also predicts cv disease. Lipoproteinassociated phospholipase a2 lppla2 antibodies. Lipoproteinassociated phospholipase a 2 springerlink. Lipoprotein associated phospholipase a2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the prove ittimi 22 pravastatin or atorvastatin evaluation and infection therapythrombolysis in myocardial infarction trial. Elevated plasma lipoprotein associated phospholipase a2 activity is associated with plaque rupture in patients with coronary artery disease. Coronary heart disease, lipoproteinassociated phospholipase a2, darapladib, inflammation, myocardial infarction, atherosclerosis. Elevated plasma lipoproteinassociated phospholipase a2 activity is associated with plaque rupture in patients with coronary artery disease. Lipoproteinassociated phospholipase a2 lp pla2, also known as plateletactivating factor acetylhydrolase, is an enzyme that hydrolyzes phospholipids and is primarily associated with ldls. Jul 28, 2015 the new lipoprotein associated phospholipase a2 activity, serum, test is now available to the mayo clinic practice and mayo medical laboratories clients. Measurement of lipoproteinassociated phospholipase a2 lp. Lipoproteinassociated phospholipase a2 lppla2, a novel plasma biomarker, circulates in the blood bound mainly to lowdensity lipoprotein ldl and promotes vascular inflammation. Lipoproteinassociated phospholipase a2 and its relationship with markers of subclinical cardiovascular disease.
Lipoproteinassociated phospholipase a2 and coronary heart. Mass levels of lipoproteinassociated phospholipase a 2 lppl a 2, a leukocytederived enzyme involved in the metabolism of lowdensity lipoprotein to proinflammatory mediators, are associated with prognosis after stroke. Lipoproteinassociated phospholipase a2 lppla2 antigen profile protein summary the protein encoded by this gene is a secreted enzyme that catalyzes the degradation of plateletactivating factor to biologically inactive products. Pdf inflammation is thought to play an important role in the. Research article comparison of lipoproteinassociated. Lipoproteinassociated phospholipase a2 activity in obese. Lipoproteinassociated phospholipase a 2 lppla 2 also known as plateletactivating factor acetylhydrolase pafah is a phospholipase a 2 enzyme that in humans is encoded by the pla2g7 gene. Laertes lipoproteinassociated phospholipase a2 in stable coronary artery disease study, which is an ongoing prospective, hospitalbased study investigating the prognostic impact of lppla 2 in stable cad. These findings necessitate the need for more reliable and accurate biomarkers to predict cvd. Lipoproteinassociated phospholipase a2 american journal of. Lipoprotein associated phospholipase a 2 mass was measured with an enzymelinked immunoassay according to previously described methods. Lipoproteinassociated phospholipase a2 predicts 5year cardiac mortality independently of established risk factors and adds prognostic information in patients with low and medium highsensitivity creactive protein the ludwigshafen risk and. Custom preparations, technical support, bulk quantities and aliquoting available, email. May 09, 2019 lipoprotein associated phospholipase a2, or lppla2, is an enzyme that travels alongside lowdensity lipoprotein ldl.
Lactam inhibitor of lipoproteinassociated phospholipase a2 lppla2. Lipoproteinassociated phospholipase a 2 lp pla 2 is an enzyme that appears to play a role in the inflammation of blood vessels and is thought to help promote atherosclerosis. Lipoproteinassociated phospholipase a 2 lppla 2is an enzyme that has demonstrated proin. Measurement of lipoproteinassociated phospholipase a2 lp pla2 in the assessment of cardiovascular risk 4.
Lipoproteinassociated phospholipase a2 lp pla2 antibody. Lipoproteinassociated phospholipase a2 lppla2, also known as plateletactivating factor. Lipoprotein associated phospholipase a2 lppla2, a novel plasma biomarker, circulates in the blood bound mainly to lowdensity lipoprotein ldl and promotes vascular inflammation. Lipoproteinassociated phospholipase a2 activity and risk. Lipoproteinassociated phospholipase a2, plateletactivating factor acetylhydrolase, generates two bioactive products during the oxidation of low. Measurement of lipoproteinassociated phospholipase a2 lppla2 in the assessment of cardiovascular risk 2 background lowdensity lipoproteins ldl have been identified as the major atherogenic lipoproteins and have long been identified by the national cholesterol education project ncep as the primary target of cholesterollowering therapy. Another fragment, 33, was confirmed to bind near the binding pocket of 32, and merging these. Lipoprotein associated phospholipase a 2 lppla 2 also known as plateletactivating factor acetylhydrolase pafah is a phospholipase a 2 enzyme that in humans is encoded by the pla2g7 gene.
Lipoprotein associated phospholipase a2 lppla 2 is a novel biomarker of vascularspecific inflammation that provides information about atherosclerotic plaque inflammation and stability. Lipoproteinassociated phospholipase a2 lp pla2 progenitor cells and coronary atherosclerosis in humans the safety and scientific validity of this study is the. Lipoproteinassociated phospholipase a 2 lppla 2 is an enzyme produced by white blood cells, notably macrophages and lymphocytes. There are no reports comparing these markers as predictors of ms. Lipoprotein associated phospholipase a2 lppla2 has been hypothesized to be involved in atherogenesis through pathways related to inflammation. Lipoproteinassociated phospholipase a2 as an independent. Siscapa, stable isotope standards and capture by antipeptide antibody. In both primary and secondary prevention study populations, lppla2 was consistently associated with higher cardiovascular risk, and the risk estimate appears to be relatively unaffected by. Is lipoprotein associated phospholipase a2 activity correlated with. The lipoproteinassociated phospholipase a2 lppla2plac test is typically used to assess a persons risk for certain types of cardiovascular disease as well as events like a heart attack. The aim of this study was to investigate the role of lppla 2 in the ischemic stroke and further offer clinical evidence that measuring lppla 2 helps predict the risk of stroke occurrence and recurrence. The lipoprotein associated phospholipase a2 lppla2plac test is typically used to assess a persons risk for certain types of cardiovascular disease as well as events like a heart attack. It is an enzyme produced by macrophages that hydrolyzes phospholipids of oxidized lowdensity lipoprotein ldl, releasing oxidized fatty acids and lysophosphatidylcholine, which are potent proin ammatory and prooxidative molecules. In the circulation, approximately 80% oflppla 2 is bound to ldl particles, where it hydrolyzes phospholipids within oxidized ldl, thereby leading to the production of the proinflammatory byproducts lysophosphatidylcholineand oxidized fatty acids.
Lipoproteinassociated phospholipase a2 lppla2 has been hypothesized to be involved in atherogenesis through pathways related to inflammation. The aim of this study is to establish lipoprotein associated phospholipase a2 lppla2 reference intervals ris in healthy chinese han adults as a clinical diagnostic indicator according to the clinical and laboratory standards institute clsi c28a3 guidelines. Lipoproteinassociated phospholipase a2 lppla2 plac. Lipoprotein associated phospholipase a2 is a proinflammatory enzyme secreted by macrophages that is primarily bound to ldl in the circulation. Lipoproteinassociated phospholipase a2 bound on high. Lipoproteinassociated phospholipase a2 lppla2 is a calciumindependent phospholipase a2 enzyme secreted by leukocytes and associated with circulating lowdensity lipoprotein and macrophages in atherosclerotic plaques. Lipoproteinassociated phospholipase a2, creactive protein, and fibrinogen levels, and the whitecell count were measured at base line, along with other traditional risk factors. Lppla2 levels in 763 healthy chinese han subjects 392 males and 371 females were determined by colorimetric analysis and the. Lipoproteinassociated phospholipase a2 lppla2 antibody.
A total of 328 hospitalized patients were recruited. Lipoproteinassociated phospholipase a2 activity, serum. Relation of secretory and lipoproteinassociated phospholipase a2 activities to a carotid artery plaque secretoryassociated phospholipase a2 odds ratio or 1. Several epidemiological studies have shown that circulating levels of lppla2 are an independent risk factor for cardiovascular events. Lee biosolutions is the leading supplier of recombinant human lipoprotein associated phospholipase a2 lppla2 antigen for life science, laboratory, research and diagnostic manufacturing uses. Oct, 2017 lipoprotein associated phospholipase a2 lppla2 was identified as a strong predictor for cardiovascular events. Lipoproteinassociated phospholipase a2 lp pla2, in vitro, antibody cat. Dietary, lifestyle, and clinical predictors of lipoproteinassociated. Lipoprotein associated phospholipase a2 lppla2 antigen profile protein summary the protein encoded by this gene is a secreted enzyme that catalyzes the degradation of plateletactivating factor to biologically inactive products. The role of lipoprotein associated phospholipase a 2 lppla 2 enzyme lppla 2 secreted protein 45kda expressed by macrophages, monocytes, t cells and mast cells, circulates in plasma in humans 80% carried by low density lipoprotein ldl molecules catalyses hydrolysis of phospholipids on. There is a strong association between lipoprotein associated phospholipase a 2 lppla 2 levels and atherosclerosisrelated diseases. Previously, studies have confirmed lipoproteinassociated phospholipase a2 lppla2 as a novel type of inflammatory marker in coronary heart. Accumulating evidence has suggested that lppla2 is a biomarker of cad and may have a proinflammatory role in the progression of atherosclerosis. Lee biosolutions is the leading supplier of recombinant human lipoproteinassociated phospholipase a2 lppla2 antigen for life science, laboratory, research and diagnostic manufacturing uses.
The elevated lipoproteinassociated phospholipase a2. This test measures the amount or activity of lp pla 2 in the blood some recent studies have shown that lp pla 2 is an independent risk marker for cardiovascular disease cvd, including coronary heart disease chd. Coronary heart disease, lipoprotein associated phospholipase a2, darapladib, inflammation, myocardial infarction, atherosclerosis. Patients with high lipoprotein associated phospholipase a2 concentrations greater than or equal to 235 ngml are at increased risk for cardiovascular events including myocardial infarction and ischemic stroke.
Lipoproteinassociated phospholipase a2 bound on highdensity. Lipoproteinassociated phospholipase a lppla is a recently described in ammatory marker. Recombinant human lipoproteinassociated phospholipase a2 lppla2 cat. Some recent studies have shown that lppla 2 is an independent risk marker for cardiovascular. Mean levels of both lppla2 and creactive protein were. Sep 26, 2017 lipoprotein associated phospholipase a2, plateletactivating factor acetylhydrolase, generates two bioactive products during the oxidation of lowdensity lipoprotein. Lppla 2 is a calciumindependent phospholipase a2 enzyme that is associated with both lowdensity lipoprotein ldl and, to a lesser extent, highdensity lipoprotein hdl in human plasma and serum 1 and is distinct from other such phospholipases such as cpla 2 and spla 2. Lppla2 is an enzyme specific to arterial inflammation making it a promising biomarker for predicting the development of cvd.
Therefore, we compared lppla2 activity between two obese age, sex, and bmimatched. Lipoproteinassociated phospholipase a2 lppla2 is an emerging inflammatory marker that is used to assess the risk for cardiovascular disease cvd and associated events. Lipoproteinassociated phospholipase a2 pathophysiological. Lipoproteinassociated phospholipase a2 health encyclopedia.
In the last decades, the role of inflammation in the pathogenesis of atherosclerosis has been the topic of intense research. Measurement of lipoproteinassociated phospholipase a2. Lipoproteinassociated phospholipase a2 is a proinflammatory enzyme secreted by macrophages that is primarily bound to ldl in the circulation. Lipoproteinassociated phospholipase 2 definition of. This study was undertaken to assess the role of lipoprotein associated phospholipase a2 lp pla2 as a biomarker to predict cvd in patients with metabolic syndrome ms among south indian population. Lipoproteinassociated phospholipase a2 an overview. This test looks for a specific lipoprotein, lppla2, in your blood.
Lipoproteinassociated phospholipase a2 lppla2 progenitor. Measurement of lipoprotein associated phospholipase a2 lp pla2 in the assessment of cardiovascular risk 4. Lipoproteinassociated phospholipase a2 test request a test. Lipoproteinassociated phospholipase a2 does this test have other names. Lipoproteinassociated phospholipase a2 has been shown to be an independent risk factor for coronary heart disease and ischemic stroke in several studies. Lipoprotein associated phospholipase a 2 lppla 2 is an enzyme that appears to play a role in the inflammation of blood vessels and is thought to help promote atherosclerosis. Crosssectional study comparing lppla2 and hscrp as predictors of ms in asymptomatic subjects was carried out. Is lipoproteinassociated phospholipase a2 activity correlated with. Pdf recent developments with lipoproteinassociated. Measurement of lipoprotein associated phospholipase a2 lppla2 in the assessment of cardiovascular risk 2 background lowdensity lipoproteins ldl have been identified as the major atherogenic lipoproteins and have long been identified by the national cholesterol education project ncep as the primary target of cholesterollowering therapy. Pafah catalyzes the removal of the acyl group at the sn2 position of paf and truncated phospholipids generated in settings of. The elevated lipoproteinassociated phospholipase a2 activit. Lppla2 hydrolyzes plateletactivating factor paf and oxidizes phospholipids with a modified short fatty acyl chain esterified at the sn2 position. Pla2 belongs to group vii of the pla2 superfamily, which currently comprises of six types and is divided into 16 unique groups.
Aug 16, 2012 the role of inflammation in atherosclerosis continues to emerge. Why measure lppla 2 measure lipoproteinassociated phospholipase a2 lppla 2, which in some studies has demonstrated more specificity than hscrp, when it is necessary to further stratify an individuals ascvd risk, especially in the presence of hscrp elevations grade a. Evidence has gathered that inflammation plays a crucial. Fragmentbased approach to the development of an orally. Lipoprotein associated phospholipase a2 has been shown to be an independent risk factor for coronary heart disease and ischemic stroke in several studies. In east asians, a lossoffunction variant in the pla2g7 gene can be used to assess the effects of genetically determined lower lppla 2. Lipoprotein associated phospholipase a2 lppla2 also predicts cv disease. The plac test for lppla 2 activity is an enzyme assay for the in vitro quantitative determination of lppla 2 lipoproteinassociated phospholipase a 2 activity in edta plasma and serum on automated clinical chemistry analyzers. The lipoprotein associated phospholipase a2, immunoassay, system, test, is intended to measure lipoprotein associated phospholipase a2 in human plasma in conjunction with clinical evaluation and other patient risk factors including biochemical analyses as an aid in predicting risk for coronary heat disease. Lipoprotein associated phospholipase a2 lppla2 as an.
Comparison of lipoproteinassociated phospholipase a2 and. Ballantyne and colleagues 7 studied lppla2 in the 12,762 apparently healthy individuals participating in the aric study. Lipoproteinassociated phospholipase a2 lppla2 was identified as a strong predictor for cardiovascular events. No matter where you are in your career, we would welcome you and encourage you to consider joining our community. Lipoproteinassociated phospholipase a2 as a predictive.
Both baseline and most recent lipoproteinassociated phospholipase a2 activity levels are associated with coronary artery calcification in type 1 diabetes lipoproteinassociated phospho lipoproteinassociated phospholipase a2 lppla2 activity has previously been associated with coronary artery calcification cac, however this relationship has not been well studied in type 1 diabetes t1d. Lipoproteinassociated phospholipase a2 and its relationship. Lipoproteinassociated phospholipase a2, or lppla2, is an enzyme that travels alongside lowdensity lipoprotein ldl. There is a strong association between lipoproteinassociated phospholipase a 2 lppla 2 levels and atherosclerosisrelated diseases. Lipoprotein associated phospholipase a2 the journal of lipid. This test measures the amount or activity of lppla 2 in the blood. Pdf lipoproteinassociated phospholipase a2 and risk of. Evidence has gathered that inflammation plays a crucial role in the triggering and progression of atherosclerosis. Elevated levels of serum lppla 2 are indicative of rupture prone plaque and a strong independent predictor of cardiovascular risk, including coronary artery. Lipoprotein associated phospholipase a2 does this test have other names. Lipoprotein phospholipase a2 reference lab affiliated. Evaluation of lipoproteinassociated phospholipase a2 in. Lipoproteinassociated phospholipase a2 lp pla2 progenitor cells and coronary atherosclerosis in humans the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Lipoprotein associated phospholipase a2 lppla2 is a monomeric enzyme that catalyzes oxidized phospholipid found in ldl into lysophosphatidylcholine and oxidized fatty acid, both of which are atherogenic.
983 297 1577 19 1044 298 191 367 1123 1303 22 39 1294 1069 109 897 434 1399 336 700 1051 217 1492 760 883 346 235 197